Orthal-Forte 20 Tablets

babies: it is not applicable for babies. lactating mothers: there is no information on the use of trypsin and chymotrypsin capsules during breastfeeding. please consult your physician. pregnancy: there is no information on the use of trypsin and chymotrypsin capsules during pregnancy.
please consult your physician. driving: it is unknown whether trypsin and chymotrypsin capsule affects driving ability. if you have any symptoms that impair your ability to concentrate, do not drive. alcohol: avoid consumption of alcohol while taking trypsin and chymotrypsin tablets. liver: trypsin and chymotrypsin capsule should be used in caution with patients suffering from liver disease.
you may require a dose adjustment and regular monitoring of liver function. seek doctor advice before using this medication.
kidney: trypsin and chymotrypsin capsules should be used in caution with patients suffering from kidney disease. you may require a dose adjustment and regular monitoring of kidney function.
seek doctor advice before using this medication. .

Limited data available.

ORTHAL is a proteolytic enzyme. it works by dissolving proteins into smaller fragments, enabling them to be absorbed into the bloodstream.
once absorbed, it increases blood supply to the affected area and reduces swelling..

If you miss a dose of ORTHAL, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• it should be taken 30 minutes before a meal or as directed by your doctor. • ORTHAL capsules should be discontinued at least two weeks before a scheduled surgery because they may interfere with blood clotting. • inform your doctor if you have liver or kidney disease, or your blood clotting mechanism has problems. • do not stop the medication suddenly without informing your doctor..

• trypsin and chymotrypsin + alcohol: concurrent use may lead to an increased risk of adverse effects • trypsin and chymotrypsin + penicillin: concurrent use may lead to increased plasma concentrations of penicillin antibiotics • trypsin and chymotrypsin + heparin: concurrent use may lead to an increased risk of adverse effects • trypsin and chymotrypsin + acetylcysteine: concurrent use may lead to decreased acetylcysteine effectiveness.